Health
The drug aprotinin inhibits entry of SARS-CoV2 in host cells, study finds – Science Daily
In order for the SARS-CoV2 virus to enter host cells, its ‘spike’ protein has to be cleaved by the cell’s own enzymes — proteases. The protease inhibitor aprotinin…
In order for the SARS-CoV2 virus to enter host cells, its “spike” protein has to be cleaved by the cell’s own enzymes — proteases. The protease inhibitor aprotinin can prevent cell infection, as scientists at Goethe University, the University of Kent and the Hannover Medical School have now discovered. An aprotinin aerosol is already approved in Russia for the treatment of influenza and could readily be tested for the treatment of COVID-19.The surface of the SARS-CoV-2 virus is studded with spike…
-
General22 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Noosa News18 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
Noosa News11 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General11 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final